{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:28:12Z","timestamp":1793528892561,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euo.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:31:46Z","timestamp":1777602706000},"page":"1098-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study)"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-2152","authenticated-orcid":false,"given":"Guillaume","family":"Ploussard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Coloby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob-Val\u00e9ry","family":"Occ\u00e9an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Hou\u00e9d\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Rischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.04.007_b0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2018.19941","article-title":"Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010\u20132015","volume":"321","author":"Mahal","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2026.04.007_b0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2026.04.007_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2019.10.008","article-title":"Local failure and survival after definitive radiotherapy for aggressive prostate cancer: an individual patient-level meta-analysis of six randomized trials","volume":"77","author":"Kishan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.juro.2007.11.063","article-title":"Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer","volume":"179","author":"Zelefsky","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0025","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/ATVBAHA.119.313046","article-title":"Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary meta-analyses","volume":"40","author":"Hu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.euo.2026.04.007_b0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (Master)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0035","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.04.007_b0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.euo.2020.01.002","article-title":"Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the phoenix criteria for biochemical recurrence after curative radiotherapy","volume":"4","author":"Jansen","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.04.007_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.04.007_b0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.urology.2004.01.002","article-title":"Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography","volume":"63","author":"Gelet","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.04.007_b0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/pcan.2008.53","article-title":"Salvage HIFU for recurrent prostate cancer after radiotherapy","volume":"12","author":"Chalasani","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2026.04.007_b0065","article-title":"Oncologic outcome of salvage high-intensity focused ultrasound (HIFU) in radiorecurrent prostate cancer. A systematic review","volume":"92","author":"Maestroni","year":"2021","journal-title":"Acta Biomed"},{"key":"10.1016\/j.euo.2026.04.007_b0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bju.13766","article-title":"Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients","volume":"119","author":"Crouzet","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.04.007_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bju.13831","article-title":"Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer","volume":"120","author":"Kanthabalan","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.04.007_b0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.eururo.2024.11.006","article-title":"Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: the prospective, noninferiority, nonrandomized HIFI trial","volume":"87","author":"Ploussard","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.euo.2026.04.007_b0090","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/curroncol28040252","article-title":"Salvage radical prostatectomy for radio-recurrent prostate cancer: an updated systematic review of oncologic, histopathologic and functional outcomes and predictors of good response","volume":"28","author":"Grubm\u00fcller","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.euo.2026.04.007_b0095","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.3390\/cancers15225485","article-title":"Salvage radical prostatectomy for recurrent prostate cancer: a systematic review (French ccAFU)","volume":"15","author":"Saouli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2026.04.007_b0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved outcomes with enzalutamide in biochemically recurrent prostate cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.04.007_b0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.euo.2024.09.015","article-title":"Prostate-specific membrane antigen positron emission tomography before reaching the phoenix criteria for biochemical recurrence of prostate cancer after radiotherapy: earlier detection of recurrences","volume":"8","author":"van Altena","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.04.007_b0110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.euo.2024.09.005","article-title":"American Radium Society appropriate use criteria for the workup and treatment of local intraprostatic recurrence of prostate cancer following definitive radiotherapy","volume":"8","author":"Valle","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.04.007_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eururo.2023.09.001","article-title":"The role of multiparametric MRI and MRI-targeted biopsy in the diagnosis of radiorecurrent prostate cancer: an analysis from the FORECAST trial","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.007_b0120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41391-024-00883-3","article-title":"Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis","volume":"28","author":"Creta","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:33:02Z","timestamp":1793525582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126001124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2588931126001124"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.04.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study)","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}